New schizophrenia drug shows promise in early trial
Symptom relief
Ongoing
This study tests an experimental drug called SPG302 in 32 adults with schizophrenia to see if it can reduce symptoms like hallucinations and disorganized thinking. Participants take the drug or a placebo for a set time, and researchers measure changes in symptom severity, brain a…
Phase: PHASE2 • Sponsor: Spinogenix • Aim: Symptom relief
Last updated May 04, 2026 16:23 UTC